Ryvu Therapeutics SA Sustainability Reports
Ryvu Therapeutics S.A. is a clinical-stage biopharmaceutical company focused on the discovery and development of novel small-molecule therapies for oncology.
Sector: Professional & technical services
Country: Poland
Exchange: Warsaw Stock Exchange
ISIN: PLSELVT00013
7 reports from 2020 to 2025